Economic burden of silent mental disorders: a case study of agnosia in schizophrenia


  • Vijay Kumar Chattu Faculty of Medical Sciences, The University of The West Indies, St. Augustine, Trinidad and Tobago
  • Paula Mahon Healthcare for the Homeless, Catholic Medical Center, Manchester



Mental health, Schizophrenia, Agnosia, Delusions, Mental health action plan, Human rights


Mental health problems affect society as a whole, and not just a small, isolated segment. In developed countries with well-organized healthcare systems, between 44% and 70% of patients with mental disorders do not receive treatment whereas in developing countries the treatment gap being close to 90%. Schizophrenia is a severe mental disorder affecting more than 21 million people worldwide. People with schizophrenia are 2-2.5 times more likely to die early than the general population. The case study highlights about agnosia in a schizophrenic patient in a primary care setting and how to address the management at a broader perspective using the appropriate antipsychotic medication and ensuring the support from a family without violating the human rights of the patient. The World Economic Forum estimated that the cumulative global impact of mental disorders in terms of lost economic output will amount to US$ 16 trillion over the next 20 years, equivalent to more than 1% of the global gross domestic product. Mental health should be a concern for all of us, rather than only for those who suffer from a mental disorder. The mental health action plan 2013-2020, endorsed by the World Health Assembly in 2013, highlights the steps required to provide appropriate services for people with mental disorders including schizophrenia. A key recommendation of the action plan is to shift services from institutions to the community. Mental health must be considered a focus of renewed investment not just in terms of human development and dignity but also in terms of social and economic development.

Author Biography

Vijay Kumar Chattu, Faculty of Medical Sciences, The University of The West Indies, St. Augustine, Trinidad and Tobago

Unit of Public Health and Primary Care

Faculty of Medical Sciences


WHO. Investing in Mental Health, Department of Mental Health and Substance Dependence, Non-Communicable Diseases and Mental Health, World Health Organization, 2013, Geneva.

WHO. Mental health: facing the challenges, building solutions: report from the WHO European Ministerial Conference, WHO, 2005.

WHO. Investing in mental health: evidence for action, WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva, 2013.

Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990−2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197−223.

Integrating mental health into primary care: a global perspective. Geneva and Bangkok, World Health Organization and World Organization of Family Doctors, 2008.

Lim KL, Jacobs P, Ohinmaa A, Schopflocher D, Dewa CS. A new population-based measure of the economic burden of mental illness in Canada. Chronic Diseases in Canada. 2008;28:92-8.

McCrone P. Paying the price: the cost of mental health care in England to 2026. London, The King’s Fund, 2008.

Patel V, Chisholm D, Kirkwood BR, Mabey D. Prioritizing health problems in women in developing countries: comparing the financial burden of reproductive tract infections, anemia and depressive disorders in a community survey in India. Trop Med Int Health. 2007;12:130-9.

WHO, Schizophrenia Factsheet, April 2016, Available at: factsheets/fs397/en/. Accessed on 22 September 2017.

WHO. Mental Health Action Plan 2013-2020. World Health Organization, Geneva, 2013.




How to Cite

Chattu, V. K., & Mahon, P. (2017). Economic burden of silent mental disorders: a case study of agnosia in schizophrenia. International Journal Of Community Medicine And Public Health, 5(1), 401–404.



Case Reports